Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chia-Chi Lin

Showing results (101-110 of 231) with videos related to

Pageof 24
Sort By:
Clinical Genitourinary Cancer|May 16, 2013
The impact of gender on outcomes in patients with metastatic urothelial carcinomaLindsay Haines, Aristotle Bamias, Susan Krege, et al.
Advanced Healthcare Materials|October 7, 2025
Formulating Smart All-in-One Chitosan Hydrogel for High Performance Wound DressingChia-Chi Lin, Andi Magattang Gafur Muchlis, Ren-Jei Chung, et al.
Esophagus : Official Journal of the Japan Esophageal Society|July 11, 2022
Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinomaJhe-Cyuan Guo, Chia-Chi Lin, Chia-Lang Hsu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 15, 2022
Immunotherapy in anaplastic thyroid cancer: Case seriesShyang-Rong Shih, Kuan-Hua Chen, Kuan-Yu Lin, et al.
Oncotarget|October 6, 2017
Analyses of a whole-genome inter-clade recombination map of hepatitis delta virus suggest a host polymerase-driven and viral RNA structure-promoted template-switching mechanism for viral RNA recombinationMei Chao, Tzu-Chi Wang, Chia-Chi Lin, et al.
Cancer Immunology, Immunotherapy : CII|May 9, 2026
Cabozantinib and atezolizumab for recurrent or metastatic esophageal squamous cell carcinoma after platinum-based chemotherapy failure: a single-arm phase II study and biomarker analysisHung-Yang Kuo, Ta-Chen Huang, Chien-Huai Chuang, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 27, 2024
ADAR2 deficiency ameliorates non-alcoholic fatty liver disease and muscle atrophy through modulating serum amyloid A1Mei-Lang Kung, Tai-Hua Yang, Chia-Chi Lin, et al.
Biochemical Pharmacology|January 18, 2006
Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cellsYeong-Shiau Pu, Min-Wei Hsieh, Chuang-Wei Wang, et al.
BMC Cancer|June 2, 2026
Tertiary lymphoid structures predict outcomes of neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinomaTa-Chen Huang, Cher-Wei Liang, Yu-I Li, et al.
Anticancer Research|October 2, 2019
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint InhibitorsJhe-Cyuan Guo, Chia-Chi Lin, Chen-Yuan Lin, et al.
Pageof 24

Showing results (101-110 of 231) with videos related to

Sort By:
Pageof 24
Clinical Genitourinary Cancer|May 16, 2013
The impact of gender on outcomes in patients with metastatic urothelial carcinomaLindsay Haines, Aristotle Bamias, Susan Krege, et al.
Advanced Healthcare Materials|October 7, 2025
Formulating Smart All-in-One Chitosan Hydrogel for High Performance Wound DressingChia-Chi Lin, Andi Magattang Gafur Muchlis, Ren-Jei Chung, et al.
Esophagus : Official Journal of the Japan Esophageal Society|July 11, 2022
Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinomaJhe-Cyuan Guo, Chia-Chi Lin, Chia-Lang Hsu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 15, 2022
Immunotherapy in anaplastic thyroid cancer: Case seriesShyang-Rong Shih, Kuan-Hua Chen, Kuan-Yu Lin, et al.
Oncotarget|October 6, 2017
Analyses of a whole-genome inter-clade recombination map of hepatitis delta virus suggest a host polymerase-driven and viral RNA structure-promoted template-switching mechanism for viral RNA recombinationMei Chao, Tzu-Chi Wang, Chia-Chi Lin, et al.
Cancer Immunology, Immunotherapy : CII|May 9, 2026
Cabozantinib and atezolizumab for recurrent or metastatic esophageal squamous cell carcinoma after platinum-based chemotherapy failure: a single-arm phase II study and biomarker analysisHung-Yang Kuo, Ta-Chen Huang, Chien-Huai Chuang, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 27, 2024
ADAR2 deficiency ameliorates non-alcoholic fatty liver disease and muscle atrophy through modulating serum amyloid A1Mei-Lang Kung, Tai-Hua Yang, Chia-Chi Lin, et al.
Biochemical Pharmacology|January 18, 2006
Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cellsYeong-Shiau Pu, Min-Wei Hsieh, Chuang-Wei Wang, et al.
BMC Cancer|June 2, 2026
Tertiary lymphoid structures predict outcomes of neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinomaTa-Chen Huang, Cher-Wei Liang, Yu-I Li, et al.
Anticancer Research|October 2, 2019
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint InhibitorsJhe-Cyuan Guo, Chia-Chi Lin, Chen-Yuan Lin, et al.
Pageof 24